HUM Humana Inc

$397.09
$2.66 (0.67%)

HUM Stock Analysis Overview

What this means: Humana Inc (HUM) gets a very positive evaluation from InvestorsObserver's ranking system. An Overall Rank of 80 means that our comprehensive methodology rates Humana Inc above 80% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full HUM report

Humana Inc (HUM) Analyst Forecast

Next 12 months ➝Current Price$397.0952-week High$412.7052-week Low$208.25MEAN$406.82+2.45%HIGH$500.00+25.92%LOW$290.00-26.97%
  • Last Price$397.09
  • Previous Close$394.43
  • Change $2.66
  • Open$404.07
  • Volume714,046
  • Avg. Volume (100-day)1,409,176
  • Market Capitalization$52B
  • Days Range $396.34 - $404.74
  • 52-week Range $208.25 - $412.70
  • Dividend Yield0.63%
  • Ex. Dividend Date06/29/2020
  • P-E20.2
  • EPS19.5
  • Earnings Date07/29/2020
  • SectorHealthcare
  • IndustryHealth Care Plans
  • Avg. Analyst Rec.
  • Beta0.456
  • PEG Ratio1.71
  • Volatility0.46
  • Average True Range0.06
Humana is one of the largest private insurance health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services and pharmacy benefit management.